Navidea Biopharmaceuticals, Inc. (NYSE: NAVB) announced that its Board of Directors has appointed Michael M. Goldberg, M.D. as President and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE